Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
Natera Analyst Ratings
Jefferies Initiates Coverage On Natera With Buy Rating, Announces Price Target of $142
Natera Inc.: Jefferies launches report with a buy rating; target share price is $142
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Dynavax (DVAX) and Natera (NTRA)
Natera Analyst Ratings
Piper Sandler Maintains Overweight on Natera, Raises Price Target to $120
Analysts' Top Healthcare Picks: Oculis Holding (OCS), Natera (NTRA)
Key Takeaways From Natera Analyst Ratings
BTIG: Maintaining the Natera (NTRA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $100.00 to $125.00.
Natera Analyst Ratings
BTIG Maintains Buy on Natera, Raises Price Target to $125
TD Cowen: Maintaining the Natera (NTRA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $123.00 to $137.00.
Natera Analyst Ratings
TD Cowen Maintains Buy on Natera, Raises Price Target to $137
UBS Boosts Price Target on Natera to $160 From $104, Keeps Buy Rating
Piper Sandler Sticks to Its Buy Rating for Natera (NTRA)
Natera Analyst Ratings
Craig-Hallum Keeps Their Buy Rating on Natera (NTRA)
Natera Analyst Ratings